氨酸脱胺酶缺乏症的评估和管理2:国际共识声明
Pui Y Lee1, Brad A Davidson2, Roshini S Abraham3
1Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
JAMA network open
|May 31, 2023
概括
腺脱氨酶2 (DADA2) 缺乏症是一种罕见的遗传疾病. 这项研究为诊断和管理DADA2提供了第一个共识指南,这对于这种严重疾病的早期干预至关重要.
科学领域:
- 遗传学和免疫学 遗传学和免疫学
- 自燃性炎症疾病 自燃性炎症疾病
- 罕见的遗传疾病 罕见的遗传疾病
背景情况:
- 氨酸脱氨酶2 (DADA2) 缺乏是导致系统性血管炎,中风和骨髓衰竭的衰减性遗传性疾病.
- DADA2影响儿童和成人,估计全球病例超过35,000例,但缺乏诊断和管理指南.
- 它是最常见的单一性自身炎症性疾病之一.
结论:
- DADA2是一种可能致命的疾病,需要及时诊断和治疗.
- 这些共识声明为评估和管理DADA2.2提供了一个重要的框架.
- 这些指导方针旨在通过规范这种罕见疾病的护理来改善患者的治疗结果.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
12
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
12
Cardiomyopathy V: Interprofessional Care
19
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
19
Dysrhythmias V: Evaluating Dysrhythmias
42
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
42
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
784
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
784
Heart Failure V: Medical Management
16
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
16
Cardiopulmonary Resuscitation III: AED Use
43
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
43


